EGFR and breast neoplasm: Epidermal growth factor receptor (EGFR) is a glycoprotein, expressed as a transmembrane tyrosine kinase receptor, is studied as a biomarker in TN breast tumours, which can be expressed in 200,000–400,000 receptors in malignant cells.